| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress










From the Departments of Pathology,*
Neurosciences,
and Reproductive
Medicine,
the University of California at San
Diego, La Jolla, California
Abnormal accumulation of the presynaptic protein
-synuclein has
recently been implicated in the pathogenesis of Alzheimers and
Parkinsons diseases. Because neurodegeneration in these conditions
might be associated with mitochondrial dysfunction and oxidative
stress, the effects of
-synuclein were investigated in a
hypothalamic neuronal cell line (GT1-7).
-Synuclein overexpression
in these cells resulted in formation of
-synuclein-immunopositive
inclusion-like structures and mitochondrial alterations accompanied by
increased levels of free radicals and decreased secretion of
gonadotropin-releasing hormone. These alterations were ameliorated by
pretreatment with anti-oxidants such as vitamin E. Taken together these
results suggest that abnormal accumulation of
-synuclein could lead
to mitochondrial alterations that may result in oxidative stress
and, eventually, cell death.
This article has been cited by other articles:
![]() |
L. Devi, V. Raghavendran, B. M. Prabhu, N. G. Avadhani, and H. K. Anandatheerthavarada Mitochondrial Import and Accumulation of {alpha}-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain J. Biol. Chem., April 4, 2008; 283(14): 9089 - 9100. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Soto and L. D. Estrada Protein Misfolding and Neurodegeneration Arch Neurol, February 1, 2008; 65(2): 184 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Steckley, M. Karajgikar, L. B. Dale, B. Fuerth, P. Swan, C. Drummond-Main, M. O. Poulter, S. S. G. Ferguson, A. Strasser, and S. P. Cregan Puma Is a Dominant Regulator of Oxidative Stress Induced Bax Activation and Neuronal Apoptosis J. Neurosci., November 21, 2007; 27(47): 12989 - 12999. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ahmad, S. Attoub, M. N. Singh, F. L. Martin, and O. M. A. El-Agnaf {gamma}-Synuclein and the progression of cancer FASEB J, November 1, 2007; 21(13): 3419 - 3430. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jin, G. J. Li, J. Davis, D. Zhu, Y. Wang, C. Pan, and J. Zhang Identification of Novel Proteins Associated with Both {alpha}-Synuclein and DJ-1 Mol. Cell. Proteomics, May 1, 2007; 6(5): 845 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Norris, K. Uryu, S. Leight, B. I. Giasson, J. Q. Trojanowski, and V. M.-Y. Lee Pesticide Exposure Exacerbates {alpha}-Synucleinopathy in an A53T Transgenic Mouse Model Am. J. Pathol., February 1, 2007; 170(2): 658 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zischka, R. J. Braun, E. P. Marantidis, D. Buringer, C. Bornhovd, S. M. Hauck, O. Demmer, C. J. Gloeckner, A. S. Reichert, F. Madeo, et al. Differential Analysis of Saccharomyces cerevisiae Mitochondria by Free Flow Electrophoresis Mol. Cell. Proteomics, November 1, 2006; 5(11): 2185 - 2200. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Arroyo, B. Kim, R. L. Rasmusson, G. Bett, and J. Yeh Hyperpolarization-Activated Cation Channels Are Expressed in Rat Hypothalamic Gonadotropin-Releasing Hormone (GnRH) Neurons and Immortalized GnRH Neurons Reproductive Sciences, September 1, 2006; 13(6): 442 - 450. [Abstract] [PDF] |
||||
![]() |
Y. Yang, S. Gehrke, Y. Imai, Z. Huang, Y. Ouyang, J.-W. Wang, L. Yang, M. F. Beal, H. Vogel, and B. Lu Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin PNAS, July 11, 2006; 103(28): 10793 - 10798. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Storz Reactive Oxygen Species-Mediated Mitochondria-to-Nucleus Signaling: A Key to Aging and Radical-Caused Diseases Sci. Signal., April 25, 2006; 2006(332): re3 - re3. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Shults Lewy bodies PNAS, February 7, 2006; 103(6): 1661 - 1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Martin, Y. Pan, A. C. Price, W. Sterling, N. G. Copeland, N. A. Jenkins, D. L. Price, and M. K. Lee Parkinson's Disease {alpha}-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death J. Neurosci., January 4, 2006; 26(1): 41 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kumar, P. Nahreini, A. J. Hanson, C. Andreatta, J. E. Prasad, and K. N. Prasad Selenomethionine Prevents Degeneration Induced by Overexpression of Wild-Type Human {alpha}-Synuclein during Differentiation of Neuroblastoma Cells J. Am. Coll. Nutr., December 1, 2005; 24(6): 516 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Silvestri, V. Caputo, E. Bellacchio, L. Atorino, B. Dallapiccola, E. M. Valente, and G. Casari Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism Hum. Mol. Genet., November 15, 2005; 14(22): 3477 - 3492. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Chung, H. Seo, K. C. Sonntag, A. Brooks, L. Lin, and O. Isacson Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection Hum. Mol. Genet., July 1, 2005; 14(13): 1709 - 1725. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ziolkowska, A. Gieryk, W. Bilecki, A. Wawrzczak-Bargiela, K. Wedzony, A. Chocyk, P. E. Danielson, E. A. Thomas, B. S. Hilbush, J. G. Sutcliffe, et al. Regulation of {alpha}-Synuclein Expression in Limbic and Motor Brain Regions of Morphine-Treated Mice J. Neurosci., May 18, 2005; 25(20): 4996 - 5003. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Callio, T. D. Oury, and C. T. Chu Manganese Superoxide Dismutase Protects against 6-Hydroxydopamine Injury in Mouse Brains J. Biol. Chem., May 6, 2005; 280(18): 18536 - 18542. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, N. Zhong, H. Wang, J. E. Elias, C. Y. Kim, I. Woldman, C. Pifl, S. P. Gygi, C. Geula, and B. A. Yankner The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis Hum. Mol. Genet., May 1, 2005; 14(9): 1231 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, T. Wang, Z. Pei, D. S. Miller, X. Wu, M. L. Block, B. Wilson, W. Zhang, Y. Zhou, J.-S. Hong, et al. Aggregated {alpha}-synuclein activates microglia: a process leading to disease progression in Parkinson's disease FASEB J, April 1, 2005; 19(6): 533 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. I. Giasson Mitochondrial Injury: A Hot Spot for Parkinsonism and Parkinson's Disease? Sci. Aging Knowl. Environ., December 1, 2004; 2004(48): pe42 - pe42. [Abstract] [Full Text] |
||||
![]() |
C. A. Wilson, D. D. Murphy, B. I. Giasson, B. Zhang, J. Q. Trojanowski, and V. M.-Y. Lee Degradative organelles containing mislocalized {alpha}- and {beta}-synuclein proliferate in presenilin-1 null neurons J. Cell Biol., May 10, 2004; 165(3): 335 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pesah, T. Pham, H. Burgess, B. Middlebrooks, P. Verstreken, Y. Zhou, M. Harding, H. Bellen, and G. Mardon Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress Development, May 1, 2004; 131(9): 2183 - 2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Palacino, D. Sagi, M. S. Goldberg, S. Krauss, C. Motz, M. Wacker, J. Klose, and J. Shen Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice J. Biol. Chem., April 30, 2004; 279(18): 18614 - 18622. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhou and C. R. Freed Tyrosine-to-Cysteine Modification of Human {alpha}-Synuclein Enhances Protein Aggregation and Cellular Toxicity J. Biol. Chem., March 12, 2004; 279(11): 10128 - 10135. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. J. Lang-Rollin, H. J. Rideout, M. Noticewala, and L. Stefanis Mechanisms of Caspase-Independent Neuronal Death: Energy Depletion and Free Radical Generation J. Neurosci., December 3, 2003; 23(35): 11015 - 11025. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Sherer, R. Betarbet, C. M. Testa, B. B. Seo, J. R. Richardson, J. H. Kim, G. W. Miller, T. Yagi, A. Matsuno-Yagi, and J. T. Greenamyre Mechanism of Toxicity in Rotenone Models of Parkinson's Disease J. Neurosci., November 26, 2003; 23(34): 10756 - 10764. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Scherzer, R. V. Jensen, S. R. Gullans, and M. B. Feany Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease Hum. Mol. Genet., October 1, 2003; 12(19): 2457 - 2466. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Park, H. Y. Jung, H. O. Kim, H. Rhim, S. R. Paik, K. C. Chung, J. H. Park, and J. Kim Evidence that alpha -synuclein functions as a negative regulator of Ca++-dependent alpha -granule release from human platelets Blood, September 18, 2002; 100(7): 2506 - 2514. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Z. Pan, W. Bruening, B. I. Giasson, V. M.-Y. Lee, and A. K. Godwin gamma -Synuclein Promotes Cancer Cell Survival and Inhibits Stress- and Chemotherapy Drug-induced Apoptosis by Modulating MAPK Pathways J. Biol. Chem., September 13, 2002; 277(38): 35050 - 35060. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. T. Power, J. M. Shannon, P. C. Blumbergs, and W.-P. Gai Nonselenium Glutathione Peroxidase in Human Brain : Elevated Levels in Parkinson's Disease and Dementia with Lewy Bodies Am. J. Pathol., September 1, 2002; 161(3): 885 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hashimoto, Y. Sagara, D. Langford, I. P. Everall, M. Mallory, A. Everson, M. Digicaylioglu, and E. Masliah Fibroblast Growth Factor 1 Regulates Signaling via the Glycogen Synthase Kinase-3beta Pathway. IMPLICATIONS FOR NEUROPROTECTION J. Biol. Chem., August 30, 2002; 277(36): 32985 - 32991. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Sherer, R. Betarbet, A. K. Stout, S. Lund, M. Baptista, A. V. Panov, M. R. Cookson, and J. T. Greenamyre An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered alpha -Synuclein Metabolism and Oxidative Damage J. Neurosci., August 15, 2002; 22(16): 7006 - 7015. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kirik, C. Rosenblad, C. Burger, C. Lundberg, T. E. Johansen, N. Muzyczka, R. J. Mandel, and A. Bjorklund Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of alpha -Synuclein in the Nigrostriatal System J. Neurosci., April 1, 2002; 22(7): 2780 - 2791. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hashimoto, L. J. Hsu, E. Rockenstein, T. Takenouchi, M. Mallory, and E. Masliah alpha -Synuclein Protects against Oxidative Stress via Inactivation of the c-Jun N-terminal Kinase Stress-signaling Pathway in Neuronal Cells J. Biol. Chem., March 22, 2002; 277(13): 11465 - 11472. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. V. Schapira Neuroprotection and dopamine agonists Neurology, February 1, 2002; 58(90001): S9 - 18. [Abstract] [Full Text] |
||||
![]() |
L. Stefanis, K. E. Larsen, H. J. Rideout, D. Sulzer, and L. A. Greene Expression of A53T Mutant But Not Wild-Type alpha -Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death J. Neurosci., December 15, 2001; 21(24): 9549 - 9560. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tsuboi, J. E. Ahlskog, H. Apaydin, J. E. Parisi, and D. W. Dickson Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls Neurology, November 13, 2001; 57(9): 1675 - 1678. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Paxinou, Q. Chen, M. Weisse, B. I. Giasson, E. H. Norris, S. M. Rueter, J. Q. Trojanowski, V. M.-Y. Lee, and H. Ischiropoulos Induction of {alpha}-Synuclein Aggregation by Intracellular Nitrative Insult J. Neurosci., October 15, 2001; 21(20): 8053 - 8061. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Masliah, E. Rockenstein, I. Veinbergs, Y. Sagara, M. Mallory, M. Hashimoto, and L. Mucke beta -Amyloid peptides enhance alpha -synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease PNAS, September 19, 2001; (2001) 211412398. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tanaka, S. Engelender, S. Igarashi, R. K. Rao, T. Wanner, R. E. Tanzi, A. Sawa, V. L. Dawson, T. M. Dawson, and C. A. Ross Inducible expression of mutant {{alpha}}-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis Hum. Mol. Genet., April 1, 2001; 10(9): 919 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iwata, M. Maruyama, I. Kanazawa, and N. Nukina alpha -Synuclein Affects the MAPK Pathway and Accelerates Cell Death J. Biol. Chem., November 21, 2001; 276(48): 45320 - 45329. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Masliah, E. Rockenstein, I. Veinbergs, Y. Sagara, M. Mallory, M. Hashimoto, and L. Mucke beta -Amyloid peptides enhance alpha -synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease PNAS, October 9, 2001; 98(21): 12245 - 12250. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |